Protection against SHIV-KB9 infection by combining rDNA and rFPV vaccines based on HIV multiepitope and p24 protein in Chinese rhesus macaques

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Li, Chang ^a   Shen, Zhenwei ^a   Li, Xiao ^a   Bai, Jieying ^a   Zeng, Lin ^a   Tian, Mingyao ^a   Song, Ying Jin ^b   Ye, Ming ^a   Du, Shouwen ^a   Ren, Dayong ^a   Liu, Cunxia ^a   Zhu, Na ^a   Sun, Dandan ^a   Li, Yi ^a   Jin, Ningyi ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b TIANJIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GAMMA INTERFERON; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; RECOMBINANT DNA PVMP24; RECOMBINANT FOWLPOX VIRUS M24; UNCLASSIFIED DRUG; VIRUS RNA; DNA VACCINE; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGENICITY; INFECTION PREVENTION; MALE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; VIRUS LOAD; ANIMAL; BIOSYNTHESIS; CD4 CD8 RATIO; CHINA; DRUG EFFECT; FOWLPOX VIRUS; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; PHYSIOLOGY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VIROLOGY;

AIDS VACCINES; ANIMALS; CD4-CD8 RATIO; CHINA; DNA, VIRAL; FEMALE; FOWLPOX VIRUS; HIV; HIV ANTIBODIES; HIV CORE PROTEIN P24; HIV INFECTIONS; HUMANS; IMMUNIZATION, SECONDARY; INJECTIONS, INTRAMUSCULAR; INTERFERON-GAMMA; MACACA MULATTA; MALE; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VACCINES, DNA; VIRAL LOAD;

EID: 84863266649     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/958404     Document Type: Article

References (51)

1. Sinoussi F. B., Chermann J. C., Rey F., Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS) Science 1983 220 4599 868 871 (Pubitemid 13080157)
2. http://www.unaids.org/globalreport/documents/20101123GlobalReportfullen. pdf
3. Girard M. P., Osmanov S. K., Kieny M. P., A review of vaccine research and development: the human immunodeficiency virus (HIV) Vaccine 2006 24 19 4062 4081
4. Barouch D. H., Challenges in the development of an HIV-1 vaccine Nature 2008 455 7213 613 619
5. Cohen M. S., Hellmann N., Levy J. A., Decock K., Lange J., The spread, treatment, and prevention of HIV-1: evolution of a global pandemic Journal of Clinical Investigation 2008 118 4 1244 1254 (Pubitemid 351500417)
6. Thomas C., Roadblocks in HIV research: five questions Nature Medicine 2009 15 8 855 859
7. Fauci A. S., 25 years of HIV Nature 2008 453 7193 289 290 (Pubitemid 351693111)
8. Wainberg M. A., Jeang K. T., 25 years of HIV-1 researchprogress and perspectives BMC Medicine 2008 6 31
9. Haigwood N. L., Hirsch V. M., Blocking and tackling HIV Nature Medicine 2009 15 8 841 842
10. Andersson J., HIV after 25 years: how to induce a vaccine? Journal of Internal Medicine 2008 263 3 215 217 (Pubitemid 351207352)
11. Brinckmann S., da Costa K., van Gils M. J., Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010 Journal of Translational Medicine 2011 9 40
12. Allen T. M., Altfeld M., Geer S. C., Kalife E. T., Moore C., O'Sullivan K. M., DeSouza I., Feeney M. E., Eldridge R. L., Maier E. L., Kaufmann D. E., Lahaie M. P., Reyor L., Tanzi G., Johnston M. N., Brander C., Draenert R., Rockstroh J. K., Jessen H., Rosenberg E. S., Mallal S. A., Walker B. D., Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution Journal of Virology 2005 79 21 13239 13249 (Pubitemid 41508139)
13. Kiepiela P., Ngumbela K., Thobakgale C., Ramduth D., Honeyborne I., Moodley E., Reddy S., De Pierres C., Mncube Z., Mkhwanazi N., Bishop K., Van Der Stok M., Nair K., Khan N., Crawford H., Payne R., Leslie A., Prado J., Prendergast A., Frater J., McCarthy N., Brander C., Learn G. H., Nickle D., Rousseau C., Coovadia H., Mullins J. I., Heckerman D., Walker B. D., Goulder P., CD8+ T-cell responses to different HIV proteins have discordant associations with viral load Nature Medicine 2007 13 1 46 53 (Pubitemid 46067385)
14. Watkins D. I., The hope for an HIV vaccine based on induction of CD8+ T lymphocytesa review Memorias do Instituto Oswaldo Cruz 2008 103 2 119 129 (Pubitemid 351535005)
15. Chen H., Piechocka-Trocha A., Miura T., Brockman M. A., Julg B. D., Baker B. M., Rothchild A. C., Block B. L., Schneidewind A., Koibuchi T., Pereyra F., Allen T. M., Walker B. D., Differential neutralization of human immunodeficiency virus (HIV) replication in autologous CD4 T cells by HIV-specific cytotoxic T lymphocytes Journal of Virology 2009 83 7 3138 3149
16. Blish C. A., Sather D. N., Sellhorn G., Stamatatos L., Sun Y., Srivastava I., Barnett S. W., Cleveland B., Overbaugh J., Hu S. L., Comparative immunogenicity of subtype A human immunodeficiency virus type 1 envelope exhibiting differential exposure of conserved neutralization epitopes Journal of Virology 2010 84 5 2573 2584
17. Shu Y., Winfrey S., Yang Z. Y., Xu L., Rao S. S., Srivastava I., Barnett S. W., Nabel G. J., Mascola J. R., Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs Vaccine 2007 25 8 1398 1408 (Pubitemid 46074300)
18. Li Z., Jin N. Y., Jin H. T., Construction and immunogenicity of multiple-epitope DNA vaccine against HIV Chinese Journal of Biologicals 2007 20 3 178 180 (Pubitemid 351165993)
19. Shen Z. W., Jin H. T., Li C., Cong Y. Z., Nan W. L., Bai L., Jin N. Y., Adjuvant effects of dual co-stimulatory molecules on cellular responses to HIV multiple-epitope DNA vaccination Chemical Research in Chinese Universities 2009 25 3 347 352
20. Zhang L., Jin N., Song Y., Wang H., Ma H., Li Z., Jiang W., Construction and characterization of a recombinant fowlpox virus containing HIV-1 multi-epitope-p24 chimeric gene in mice Science in China Series C 2007 50 2 212 220 (Pubitemid 46643877)
21. Byum A., Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g Scandinavian Journal of Clinical and Laboratory Investigation, Supplement 1968 97 77 89
22. Desrosiers R. C., Ringler D. J., Use of simian immunodeficiency viruses for AIDS research Intervirology 1989 30 6 301 312 (Pubitemid 20038058)
23. Desrosiers R. C., Wyand M. S., Kodama T., Ringler D. J., Arthur L. O., Sehgal P. K., Letvin N. L., King N. W., Daniel M. D., Vaccine protection against simian immunodeficiency virus infection Proceedings of the National Academy of Sciences of the United States of America 1989 86 16 6353 6357 (Pubitemid 19210650)
24. Li J. T., Halloran M., Lord C. I., Watson A., Ranchalis J., Fung M., Letvin N. L., Sodroski J. G., Persistent infection of macaques with simian-human immunodeficiency viruses Journal of Virology 1995 69 11 7061 7071
25. Joag S. V., Li Z., Foresman L., Stephens E. B., Zhao L. J., Adany I., Pinson D. M., McClure H. M., Narayan O., Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques Journal of Virology 1996 70 5 3189 3197 (Pubitemid 26121937)
26. Dunn C. S., Beyer C., Kieny M. P., Gloeckler L., Schmitt D., Gut J. P., Kirn A., Aubertin A. M., High viral load and CD4 lymphopenia in rhesus and cynomolgus macaques infected by a chimeric primate lentivirus constructed using the env, rev, tat, and vpu genes from HIV-1 Lai Virology 1996 223 2 351 361 (Pubitemid 26319595)
27. Narayan S. V., Mukherjee S., Jia F., Li Z., Wang C., Foresman L., McCormick-Davis C., Stephens E. B., Joag S. V., Narayan O., Characterization of a neutralization-escape variant of SHIV(KU-1), a virus that causes acquired immune deficiency syndrome in pig-tailed macaques Virology 1999 256 1 54 63 (Pubitemid 29391826)
28. Joag S. V., Primate models of AIDS Microbes and Infection 2000 2 2 223 229 (Pubitemid 30154711)
29. Johnston M. I., The role of nonhuman primate models in AIDS vaccine development Molecular Medicine Today 2000 6 7 267 270 (Pubitemid 30429181)
30. Heeney J. L., Primate models for AIDS vaccine development AIDS 1996 10 supplement A S115 122
31. Karlsson G. B., Halloran M., Li J., Park I. W., Gomila R., Reimann K. A., Axthelm M. K., Iliff S. A., Letvin N. L., Sodroski J., Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys Journal of Virology 1997 71 6 4218 4225 (Pubitemid 27204107)
32. Cohen J., AIDS research. Vaccine studies stymied by shortage of animals Science 2000 287 5455 959 960 (Pubitemid 30094332)
33. Ling B., Veazey R. S., Luckay A., Penedo C., Xu K., Lifson J. D., Marx P. A., SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans AIDS 2002 16 11 1489 1496 (Pubitemid 34804213)
34. Crowe S., SIVmac pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans, by Stellbrink et al AIDS 2003 17 supplement 4 S107 S108
35. Monceaux V., Viollet L., Petit F., Cumont M. C., Kaufmann G. R., Aubertin A. M., Hurtrel B., Silvestri G., Estaquier J., CD4+ CCR5+ T-cell dynamics during simian immunodeficiency virus infection of Chinese rhesus macaques Journal of Virology 2007 81 24 13865 13875 (Pubitemid 350247880)
36. Balter M., Can immune systems be trained to fight HIV? Science 1999 286 5444 1470 1471
37. Cohen J., AIDS research. Novel protein delivers HIV to target cells Science 2000 287 5458 1567 (Pubitemid 30127730)
38. Rappuoli R., Aderem A., A 2020 vision for vaccines against HIV, tuberculosis and malaria Nature 2011 473 7348 463 469
39. Virgin H. W., Walker B. D., Immunology and the elusive AIDS vaccine Nature 2010 464 7286 224 231
40. Lu J., Wang C., Zhou Z., Cai C., Zhang Y., Cao T., Shi C., Chen Z., Chen L., Fan X., Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein Clinical and Developmental Immunology 2011 2011 10
41. Paris R. M., Kim J. H., Robb M. L., Michael N. L., Prime-boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1 Expert Review of Vaccines 2010 9 9 1055 1069
42. Letvin N. L., Progress in the development of an HIV-1 vaccine Science 1998 280 5371 1875 1880 (Pubitemid 28299383)
43. Bazhan S. I., Belavin P. A., Seregin S. V., Danilyuk N. K., Babkina I. N., Karpenko L. I., Nekrasova N. A., Lebedev L. R., Ignatyev G. M., Agafonov A. P., Poryvaeva V. A., Aborneva I. V., Ilyichev A. A., Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigens Vaccine 2004 22 13-14 1672 1682 (Pubitemid 38447215)
44. Su J., Luscher M. A., Xiong Y., Rustam T., Amara R. R., Rakasz E., Robinson H. L., MacDonald K. S., Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques International Immunology 2005 17 5 637 648 (Pubitemid 41417861)
45. Brown S. A., Surman S. L., Sealy R., Jones B. G., Slobod K. S., Branum K., Lockey T. D., Howlett N., Freiden P., Flynn P., Hurwitz J. L., Heterologous prime-boost HIV-1 vaccination regimens in pre-clinical and clinical trials Viruses 2010 2 2 435 467
46. Ramsay A. J., Leong K. H., Ramshaw I. A., DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors Immunology and Cell Biology 1997 75 4 382 388 (Pubitemid 27408046)
47. McShane H., Prime-boost immunization strategies for infectious diseases Current Opinion in Molecular Therapeutics 2002 4 1 23 27 (Pubitemid 34649789)
48. Kent S. J., Zhao A., Best S. J., Chandler J. D., Boyle D. B., Ramshaw I. A., Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus Journal of Virology 1998 72 12 10180 10188 (Pubitemid 28520889)
49. Li X., Jin N., Mi Z., Lian H., Sun L., Li X., Zheng H., Antitumor effects of a recombinant fowlpox virus expressing Apoptin in vivo and in vitro International Journal of Cancer 2006 119 12 2948 2957 (Pubitemid 44846250)
50. Ma M., Jin N., Shen G., Zhu G., Liu H. J., Zheng M., Lu H., Huo X., Jin M., Yin G., Ma H., Li X., Ji Y., Jin K., Immune responses of swine inoculated with a recombinant fowlpox virus co-expressing P12A and 3C of FMDV and swine IL-18 Veterinary Immunology and Immunopathology 2008 121 1-2 1 7 (Pubitemid 350235644)
51. Qiao C., Jiang Y., Tian G., Wang X., Li C., Xin X., Chen H., Yu K., Recombinant fowlpox virus vector-based vaccine completely protects chickens from H5N1 avian influenza virus Antiviral Research 2009 81 3 234 238